Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation

Stopped The study was terminated due to slow rate of accrual resulting in a sample size.

Conditions

• Atrial Fibrillation New Onset
• Hemorrhage
• Prolonged QTc Interval
• Ventricular Tachycardia
• Medical Care; Complications, Late Effect of Complications

Interventions

• DRUG: Ranolazine
• DRUG: Placebo

Sponsor

Northwell Health

Collaborators

• [object Object]